Evaluating Reverse-Translating Human Target Evidence to Investigate in Preclinical Models
Time: 11:00 am
day: Pre-Conference Day Track B 2
Details:
Successful translation into the clinic remains a major hurdle in the neuroimmunology field. Join this workshop to discuss the debate the back translation of human target evidence to investigate and validate in preclinical models.
Workshop highlights include:
• Exploring challenges and achievements of reversetranslation in glial target validation
• Using human evidence from genetic and biomarker studies to inform hypothesis testing in preclinical models
• Capitalizing on consortia biomarker data to accelerate back translation and therapeutic development
